striver44
BANNED
- Jul 25, 2016
- 4,832
- -16
- Country
- Location
Nation’s emergency-use approval comes despite trial results placing the shot at 65.3%, the low end of efficacy range
What China and Russia Could Reap From Covid-19 Vaccine Diplomacy
YOU MAY ALSO LIKE
UP NEXT
0:00 / 6:11
What China and Russia Could Reap From Covid-19 Vaccine Diplomacy
As wealthier countries buy up supplies of Western drugmakers’ Covid-19 vaccines that are still in development, China and Russia are offering their fast-tracked shots to poorer nations. Here’s what they're hoping to get in return. Illustration: Ksenia Shaikhutdinova (Originally published Oct. 14, 2020)
By
Chao Deng
and
Jon Emont
Jan. 11, 2021 8:48 am ET
Indonesia became the first country outside China to give emergency use approval to a Covid-19 vaccine developed by Chinese drugmaker Sinovac Biotech Ltd., despite findings that place the candidate’s efficacy among the lowest for new coronavirus vaccines.
Indonesia’s food and drug agency said Monday that a late-stage clinical trial in the large city of Bandung showed Sinovac’s CoronaVac vaccine to be 65.3% effective. That compares to clinical trial results out of Brazil last week showing the vaccine had an efficacy rate of 78%.
Indonesia’s trial showed that CoronaVac was safe, with participants experiencing only minor side effects like fatigue and fever, according to Penny Lukito, the head of Indonesia’s National Agency of Drug and Food Control. “Hopefully vaccines for Covid-19 will be one of the factors in overcoming this pandemic,” she said.
A rate of 65% exceeds the 50% threshold that the World Health Organization and many regulatory authorities consider necessary for widespread use. Western vaccines developed by Moderna Inc. and jointly by Pfizer Inc. and BioNTech SE have reported their vaccines to be more than 90% effective; another developed by the University of Oxford and AstraZeneca PLC was at least 62% effective, according to the team.
www.wsj.com
=====
If it was me I'll wait in 3 months. if we have reports of people getting any fatal side effects after they receive the vaccine. Many people I've talked to as well as some internet comments research showed that many are not in a rush to have this "chinese" vaccine.
If everything is fine, then it's a go.
What China and Russia Could Reap From Covid-19 Vaccine Diplomacy
YOU MAY ALSO LIKE
UP NEXT
0:00 / 6:11
What China and Russia Could Reap From Covid-19 Vaccine Diplomacy
As wealthier countries buy up supplies of Western drugmakers’ Covid-19 vaccines that are still in development, China and Russia are offering their fast-tracked shots to poorer nations. Here’s what they're hoping to get in return. Illustration: Ksenia Shaikhutdinova (Originally published Oct. 14, 2020)
By
Chao Deng
and
Jon Emont
Jan. 11, 2021 8:48 am ET
SHARE
TEXT
Indonesia became the first country outside China to give emergency use approval to a Covid-19 vaccine developed by Chinese drugmaker Sinovac Biotech Ltd., despite findings that place the candidate’s efficacy among the lowest for new coronavirus vaccines.
Indonesia’s food and drug agency said Monday that a late-stage clinical trial in the large city of Bandung showed Sinovac’s CoronaVac vaccine to be 65.3% effective. That compares to clinical trial results out of Brazil last week showing the vaccine had an efficacy rate of 78%.
Indonesia’s trial showed that CoronaVac was safe, with participants experiencing only minor side effects like fatigue and fever, according to Penny Lukito, the head of Indonesia’s National Agency of Drug and Food Control. “Hopefully vaccines for Covid-19 will be one of the factors in overcoming this pandemic,” she said.
A rate of 65% exceeds the 50% threshold that the World Health Organization and many regulatory authorities consider necessary for widespread use. Western vaccines developed by Moderna Inc. and jointly by Pfizer Inc. and BioNTech SE have reported their vaccines to be more than 90% effective; another developed by the University of Oxford and AstraZeneca PLC was at least 62% effective, according to the team.
Indonesia Is First to Approve Sinovac Vaccine Outside China
Nation’s emergency-use approval comes despite trial results placing the shot at 65.3%, the low end of efficacy range.
www.wsj.com
=====
If it was me I'll wait in 3 months. if we have reports of people getting any fatal side effects after they receive the vaccine. Many people I've talked to as well as some internet comments research showed that many are not in a rush to have this "chinese" vaccine.
If everything is fine, then it's a go.
